ImmunoReagents
Private Company
Funding information not available
Overview
ImmunoReagents is a private, established player in the research reagents and diagnostics supply sector, operating as a direct manufacturer since 1999. The company's core business involves the production and sale of a broad portfolio of polyclonal antibodies, conjugated secondary antibodies, and related immunoassay reagents, serving both research customers and OEM/ bulk clients in the IVD industry. It emphasizes quality, cost-effectiveness, and specificity through cross-adsorption techniques. While not a therapeutic developer, its role as a critical supplier to pharmaceutical, biotech, and diagnostic companies positions it within the broader biotechnology ecosystem.
Technology Platform
Polyclonal antibody production in multiple host species, with expertise in cross-adsorption purification and conjugation (enzymes, fluorophores, biotin) to enhance specificity for immunoassays. Manufacturing complies with cGMP/QSR for IVD use.
Opportunities
Risk Factors
Competitive Landscape
ImmunoReagents competes in the fragmented research reagents and antibodies market against giants like Thermo Fisher Scientific, Abcam, and Merck Millipore, as well as numerous specialized antibody boutiques. Its differentiation is based on being a direct US manufacturer with a focus on polyclonals, cross-adsorption for specificity, and cost-effectiveness for bulk/OEM clients in the IVD space.